Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,623 across all filing types
Latest filing 2025-08-22 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-22 English
Nomination Committee Terms of Reference
Governance Information Classification · 98% confidence The document is the Terms of Reference for the Nomination Committee, outlining internal rules, board composition, committee duties and procedures. This is a specific governance charter detailing board structure and governance practices. It is not an announcement of a report, nor an earnings or financial filing, but falls squarely under Governance Information (CGR).
2025-08-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-22 English
2025 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2025 INTERIM RESULTS ANNOUNCEMENT' and contains comprehensive unaudited consolidated financial statements, including the statement of profit or loss, statement of financial position, and detailed notes to the interim financial report for the six months ended 30 June 2025. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-22 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The provided document is the full text of RemeGen Co., Ltd.’s Articles of Association – the company’s constitutional bylaws setting out its corporate governance structures, shareholder rights, board organization, and internal rules. This matches the definition of "Governance Information" (CGR): detailed report on the company’s internal rules and governance practices. It is not a meeting announcement, regulatory notice or financial report, but the core governance charter itself.
2025-08-22 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.